Oxford BioMedica (OXBDF) Q2 2024 Earnings Report
OXBDF Q2 2024 EPS Results
- Actual EPS
- -$0.41
- Consensus EPS
- -$0.37
- Beat/Miss
- Missed by -$0.04
- One Year Ago EPS
- -$0.66
OXBDF Q2 2024 Revenue Results
- Actual Revenue
- $67.29M
- Expected Revenue
- $66.88M
- Beat/Miss
- Beat by +$405.26K
- YoY Revenue Growth
- +17.99%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 09/23/2024
- Time
- Before Open
- Conference Call
- Monday, September 23, 2024
OXBDF Upcoming Earnings
Oxford BioMedica's next earnings date is estimated for April 15, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
OXBDF Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
OXBDF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 15, 2027 | 2026 (Q4) | -0.03- | -0.07 | ― | ― |
| Sep 22, 2026 | 2026 (Q2) | -0.38-0.40 | -0.34 | -19.69% (-0.07) | |
| Mar 26, 2026 | 2025 (Q4) | -0.10-0.07 | -0.1 | 29.87% (+0.03) | |
| Sep 23, 2025 | 2025 (Q2) | -0.32-0.34 | -0.41 | 17.80% (+0.07) | |
| Apr 09, 2025 | 2024 (Q4) | -0.10-0.10 | -1.5 | 93.21% (+1.40) | |
| Sep 23, 2024 | 2024 (Q2) | -0.37-0.41 | -0.66 | 37.83% (+0.25) | |
| Apr 29, 2024 | 2023 (Q4) | -0.65-1.50 | -0.19 | -682.07% (-1.31) | |
| Sep 20, 2023 | 2023 (Q2) | -0.47-0.66 | -0.36 | -82.05% (-0.30) | |
| Apr 25, 2023 | 2022 (Q4) | -0.09-0.19 | 0.01 | -1418.18% (-0.21) | |
| Sep 15, 2022 | 2022 (Q2) | -0.10-0.36 | 0.28 | -227.57% (-0.64) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed